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Tumor-intrinsic immuno-resistance is a prerequisite for emergence of follicular lymphomas. Here we show that in vitro,
such cells are more resistant to immune cytolysis when grown as follicle-mimicking tridimensional aggregates than when
grown as cell suspensions. So in patients, this innate adaptation to tumor immunity might precede its selective pressure.
The cure of non-Hodgkin lymphomas
(NHL) largely depends upon cytolytic
lymphocytes recruited during therapy,
but most NHL cells appear relatively
resistant to their action. It is thus impor-
tant to understand how they do so. A
hallmark of follicular lymphoma is their
growth as dense aggregates in lymph
nodes, a feature however lacking from all
in vitro studies which currently involve cell
suspensions only.
Here we grew lymphoma cells in vitro
as tridimensional multicellular aggregates
(MALC) to test whether such a mode of
cell growth promotes some degree of
immuno-resistance. In this aim, MALC
of the t(14,18)
+ follicular lymphoma cell
line RL were produced in vitro by a
modified “hanging drop” method.
1,2 This
type of cell growth formed compact ovoïd
aggregates reaching a diameter of ~1 mm
by three weeks of culture, which were
never produced in the usual cell suspen-
sions in culture flasks. We then asked
whether these two kinds of cell growth
induced different gene expression profiles.
So, the transcriptomes from RL cells
grown for 10 d either as MALC or cell
suspensions were produced on Affymetrix
microarrays (HG-133 plus 2.0) and
analyzed by Autocompare.
3 451 genes
were significantly upregulated in cells
grown as MALC comparatively to cell
suspensions (. 4,p, 0.05). These were
enriched for genes upregulated in the
central area of tumors relative to periphery
(p = 10
220)
4 and for genes regulated by
the histone-lysine N-methyltransferase
gene EZH2 (p = 10
212).
5 The upregulated
MALC genes also reflected the highly
relevant hallmarks of follicular lymphoma
cells: induction of anti-apoptotic func-
tions (p = 0.0002), pro-survival NFkB
cascade (p = 0.0006) and response
to hypoxia (p = 0.002). Further, the
241 most downregulated MALC genes
(, 0.5,p, 0.05) indicated shut down
of cytokine/cytokine receptor interactions
(p = 10
27) and chemokine signaling (p =
10
25). So, lymphoma cells grown in vitro
as MALC present a gene expression
pattern which is not only highly relevant
of follicular lymphoma cells in vivo, but
also suggests a pre-adaptation to selective
pressure from immunity. This view was
strenghened when the lymphoma cells
grown either in culture flasks or MALC
were dissociated and compared as targets
in classical 4 h
51Cr-release lysis assays
by allogeneic NK cells from different
healthy donors. The lymphoma cells were
more resistant to NK lysis when grown as
MALC than when grown as cell suspen-
sions (Fig.1).
Various lymphoma cell-intrinsic





8 have been identified.
We now propose that growth as cell
aggregates represent another tumor cell-
intrinsic pathway of immuno-resistance
for follicular lymphomas. The trans-
criptome of follicular lymphoma cells
grown as MALC was characteristic of
deeply intra-tumoral cancer cells
4 and
reflected regulation by known drivers
of lymphomagenesis.
9 Together with
these features, cells from MALC
showed more anti-apoptotic and “immu-
nosilent” gene expression profiles and
they showed higher resistance to NK
lysis than cells in suspension. So when
grown aggregated in vitro, the lymphoma
cells show a remarkable tumor-intrinsic
pre-adaptation to further immune pres-
sure. These observations suggest that
natural lymphomagenesis in lymphoid
organs from patients might also involve
such an “innate” predisposition to
immune escape.
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Figure1. Follicular lymphoma cell growth in vitro as MALC increases immune resistance.
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